New YPrime Report Highlights eCOA's Impact on CNS Trials
May 01, 2024 08:00 ET
|
Y-Prime, LLC
YPrime has released a new report, Insights into CNS Clinical Trials, which demonstrates to sponsors how eCOA can help streamline CNS research.
YPrime Launches Intuitive Tender Swollen Joint Count (TSJC) Assessment for Effortless eCOA
April 30, 2024 08:00 ET
|
Y-Prime, LLC
YPrime launches its Tender Swollen Joint Count (TSJC) eCOA assessment for faster, more accurate, and user-friendly data collection in clinical research.
YPrime Survey Reveals Challenges and Opportunities for Streamlining Oncology Trials with eCOA
April 03, 2024 08:00 ET
|
Y-Prime, LLC
YPrime has released a report on the findings from a survey of oncology clinical trial professionals on their experiences with eCOA.
YPrime's Latest Research Reveals Significant Impact of eCOA Platform Delays on Clinical Trial Efficiency
January 30, 2024 08:00 ET
|
Y-Prime, LLC
YPrime eCOA research reveals stakeholders' concerns about timelines and data quality.
YPrime präsentiert eine neue Marke zur Lösung von Aspekten der Zuverlässigkeit in klinischen Studien
January 22, 2024 13:38 ET
|
Y-Prime, LLC
MALVERN, PA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- YPrime, ein führender Wegbereiter von Technologien für klinische Studien, hat heute eine kühne Initiative zur Weiterentwicklung seiner Marke...
YPrime dévoile une marque qui se veut transformatrice axée sur la résolution de la problématique du niveau de confiance dans les essais cliniques
January 22, 2024 13:38 ET
|
Y-Prime, LLC
MALVERN, Pennsylvanie, 22 janv. 2024 (GLOBE NEWSWIRE) -- YPrime, pionnier de la technologie en matière essais cliniques, annonce aujourd’hui une initiative audacieuse d’évolution de sa marque qui...
YPrime Unveils a Transformative Brand Focused on Solving for Certainty in Clinical Trials
January 22, 2024 07:45 ET
|
Y-Prime, LLC
YPrime announces bold rebranding and re-commitment to provide cutting-edge technologies to streamline and accelerate clinical trials.